FORBES-TATE for SANOFI U.S.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to Orphan Drug Tax Credit; Issues related to the excise tax for the Vaccine Injury Compensation Fund.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
Health Issues HCR
Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act (PL 78-410); Drug pricing issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to flu and RSV vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
Medicare/Medicaid MMM
Issues related to prescription drug pricing, including the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Section 340B of the Public Health Service Act (PL 78-410); Issues related to pharmacy benefit managers.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.